Zobrazeno 1 - 10
of 1 133
pro vyhledávání: '"Blanchette CM"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 51-62 (2023)
Nina Kim,1 Joaquin Estrada,2 Isabella Chow,2 Aleksandrina Ruseva,1 Abhilasha Ramasamy,1 Chakkarin Burudpakdee,1 Christopher M Blanchette1 1Novo Nordisk, Inc, Plainsboro, NJ, USA; 2IQVIA, Inc, San Francisco, CA, USACorrespondence: Aleksandrina Ruseva,
Externí odkaz:
https://doaj.org/article/f866cb1820a146f1a211084e3b245e13
Publikováno v:
International Journal of COPD, Vol Volume 15, Pp 2389-2397 (2020)
Robert Sandhaus,1 Charlie Strange,2 Glenda Stone,3 M Chris Runken,3 Christopher M Blanchette,4 Reuben Howden5 1Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA; 2Department of Pulmonary and Critical Car
Externí odkaz:
https://doaj.org/article/f9bcef66fe6b427ca69d1250e2879e5c
Publikováno v:
International Journal of COPD, Vol Volume 14, Pp 893-903 (2019)
Shweta Shah,1 Christopher M Blanchette,1 Joseph C Coyle,2 Marc Kowalkowski,3 Susan T Arthur,2 Reuben Howden1,21Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, NC, USA; 2Department of Kinesiology, University
Externí odkaz:
https://doaj.org/article/63986fd580194e62840bedd97bf87ef3
Autor:
Guptill JT, Runken MC, Eaddy M, Lunacsek OE, Fuldeore RM, Blanchette CM, Zacherle E, Noone JM
Publikováno v:
Patient Preference and Adherence, Vol Volume 13, Pp 649-655 (2019)
Jeffrey T Guptill,1 M Chris Runken,2 Michael Eaddy,3 Orsolya E Lunacsek,4 Rupali M Fuldeore,4 Christopher M Blanchette,5 Emily Zacherle,5 Joshua M Noone51Department of Neurology, Duke University, Durham, NC, USA; 2Grifols SSNA, Research Triangle Park
Externí odkaz:
https://doaj.org/article/55c26b5499f24a92bc24bbd98f092d2f
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2015, Iss default, Pp 65-72 (2015)
Steven M Brunelli,1 Christopher M Blanchette,2,3 Ami J Claxton,1 Debosree Roy,2 Sandro Rossetti,3 Benjamin Gutierrez31DaVita Clinical Research, Minneapolis, MN, USA; 2University of North Carolina, Charlotte, NC, USA; 3Otsuka America Pharmaceutical, I
Externí odkaz:
https://doaj.org/article/f8f8e8f98aae446f98622d253818486a
Publikováno v:
International Journal of COPD, Vol 2011, Iss default, Pp 573-581 (2011)
Douglas W Mapel1, Anand A Dalal2, Christopher M Blanchette3,4, Hans Petersen3, Gary T Ferguson5 1Lovelace Clinic Foundation, Albuquerque, NM, USA; 2US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA; 3Lovelace Respiratory Research I
Externí odkaz:
https://doaj.org/article/eb20800185e5478297ce9fb2283bd05e
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S348-S349
Autor:
Tang, Fang1 (AUTHOR), Xiang, Meng2 (AUTHOR), Yin, Shanshan3 (AUTHOR), Li, Xiang1 (AUTHOR), Gao, Pincao1,2 (AUTHOR) 112312@aqnu.edu.cn
Publikováno v:
BMC Musculoskeletal Disorders. 8/31/2024, Vol. 25 Issue 1, p1-20. 20p.
Autor:
Ding Y; Health Economics and Outcomes Research, Novo Nordisk, Plainsboro, NJ., Fan X; HEOR Real World Data Analytics, Novo Nordisk, Plainsboro, NJ., Blanchette CM; HEOR Strategy and Evidence Generation, Novo Nordisk, Plainsboro, NJ., Smolarz BG; US Medical Affairs, Novo Nordisk, Plainsboro, NJ., Weng W; HEOR Real World Data Analytics, Novo Nordisk, Plainsboro, NJ., Ramasamy A; HEOR Strategy and Evidence Generation, Novo Nordisk, Plainsboro, NJ.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Jan; Vol. 27 (1), pp. 37-50. Date of Electronic Publication: 2020 Nov 09.
Publikováno v:
In Value in Health October 2018 21 Supplement 3:S371-S371